Resources

All Federal grants and funding opportunities are listed and available through Grants.gov. To check your or your family’s eligibility to receive Federal benefits or assistance please visit GovBenefits.gov.

Highly Innovative Tactics to Interrupt Transmission of HIV (HIT-IT) (R01) (National Institutes of Health)
The purpose of this initiative is to foster exceptionally innovative, high risk, original and/or unique and unconventional research that, if successful, will have an unusually high impact on HIV/AIDS prevention.
Application Due Date: November 3, 2009
Earliest Anticipated Start Date: July 1, 2010

Dissecting the Early HIV Immune Response: A Systems Biology Approach (P01) (National Institutes of Health)
The goal of the HIV Systems Biology Program is to gain a more comprehensive understanding of networks or interacting components in early immune responses to HIV/SIV in order to predict systems behavior that informs the outcome of HIV/SIV exposure or infection.
Application Due Date: December 1, 2009
Earliest Anticipated Start Date: July, 2010

Oral Mucosal Vaccination against HIV Infection (R01) (National Institutes of Health)
This FOA solicits R01 applications that focus on harnessing oral mucosal and innate immunity to develop prophylactic HIV vaccines delivered through the oral mucosa.
Application Due Date: December 2, 2009
Earliest Anticipated Start Date: August 2, 2010

Phased Innovation Award Program for AIDS Vaccine Research (R21/R33) (National Institutes of Health)
This program will support preclinical prophylactic vaccine research projects that are innovative, novel, may be high risk/high impact, and that exhibit the potential to advance AIDS prophylactic vaccine design or evaluation.
Application Due Date: Cycle I: May 7, 2009, Cycle II: September 7, 2009, Cycle III: January 1, 2010
Anticipated Start Date: Cycle I: December 1, 2009, Cycle II: April 1, 2010, Cycle III: July 1, 2010

International Research in Infectious Diseases including AIDS (IRIDA) Program (R01) (National Institutes of Health )
This funding opportunity announcement (FOA) issued by the NIAID solicits Research Grant (R01) applications from organizations/institutions in eligible foreign countries that propose research related to infectious diseases that are of interest to that country.
Application Submission Receipt Date(s): For non-AIDS applications: September 16, 2008; September 16, 2009; and September 16, 2010: For AIDS applications: December 16, 2008; December 16, 2009; and December 16, 2010
Earliest Anticipated Start Date(s): July, 2009; July, 2010; July, 2011

Unique Interactions Between Tobacco Use and HIV/AIDS (R01) (National Institutes of Health)
The purpose for this FOA is to encourage Research Project Grant (R01) applications from institutions/organizations that propose to stimulate research related to the unique, interactive health effects of cigarette smoking and HIV/AIDS.
Opening Date: December 7, 2008 (Earliest date an application may be submitted to Grants.gov)
Expiration Date: January 8, 2012

Unique Interactions Between Tobacco Use and HIV/AIDS (R03) (National Institutes of Health)
The purpose for this FOA issued by the National Institute on Drug Abuse and the Fogarty International Center encourages Small Research Grant (R03) applications from institutions/organizations that propose to stimulate research related to the unique, interactive health effects of cigarette smoking and HIV/AIDS.
Opening Date: December 7, 2008 (Earliest date an application may be submitted to Grants.gov)
Expiration Date: September 8, 2011